Resource Documents
ACTA STInG Submission to the NHMRC Structural Review
Latest Resource
-
Approaches to prioritising research
for clinical trial networks: a scoping review -
HEAT Webinar Recording- Economic Evaluation Alongside Adaptive Trials
-
ACTA 2021-2022 Annual Report
-
Effective strategies to manage data integrity risks webinar
-
The Data Lifecycle: Ethical use of data webinar
-
Transparency in data analyses webinar
-
Economic evaluation alongside cluster trial – webinar recording
-
Joint webinar on estimands in clinical trials
-
Webinar: Estimands in Oncology – How and Why
-
Webinar PIONEERing estimands in Clinical Research
-
Estimands: Not just a statistical issue
-
Resource for trial statisticians planning to apply for an academic promotion
-
Development of the Consumer Involvement and Engagement Toolkit
-
Activities supporting the growth of Clinical Trial Networks in Australia
-
Strengthening the capacity, efficiency and effectiveness of Clinical Trials Networks: Activity Overview 2017–2021
-
ACTA 2020-2021 Annual Report
-
Guidance on Peer Reviewing the Statistical Aspects of a Medical Paper
-
ACTA Whistleblower Policy
-
Protocols and Statistical Analysis Plans (SAPs) for Adaptive Trials
-
MEDIA RELEASE: ACTA appoints Prof Steve Webb as its new Chair and Ian Wilson as Additional Independent Director
-
Official Opening of the 2020 ACTA Summit: Minister’s Address
-
ACTA Year in Review: Financial Year 2019-2020
-
Statistical Analysis Plan (SAP)
-
ACTA Board Charter
-
ACTA Constitution
-
ACTA Trial of the Year Award 2020 guidelines and nomination forms
-
Bayesian adaptive randomised clinical trials flyer
-
ACTA STInG grant advice for trial statisticians
-
ACTA Year in Review: Financial Year 2018-2019
-
ACTA STInG Notes from Members’ meeting, October 2019
-
ACTA Resources Brochure
-
ACTA activity work plan 2019 – 2020
-
Report on the activities and achievements of clinical trials networks in Australia 2004 – 2014
-
What a trialist should know about implementation to practice
-
Submission to MRFF Consultation
-
Submission to Medical Research Future Fund Priority Consultation